Selecta Biosciences is a biotechnology company that develops and commercializes immunotherapies for the treatment of autoimmune diseases.
Business Model:
Revenue: $123.9M
Employees: 51-200
Address: 65 Grove Street
City: Watertown
State: MA
Zip: 02472
Country: US
Selecta Biosciences is a biotechnology company that develops and commercializes immunotherapies for the treatment of autoimmune diseases.
Contact Phone:
+16179231400
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/22/2016
IPO Valuation:
$249M
Ticker Symbol:
SELB
IPO Price:
$14/share
Amount Raised:
$70M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2021 | Cyrus Biotechnology | Series B | 0 |
12/2021 | Cyrus Biotechnology | Series B | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|